Previous Article | Next Article ![]()
Infection and Immunity, April 2006, p. 2457-2461, Vol. 74, No. 4
0019-9567/06/$08.00+0 doi:10.1128/IAI.74.4.2457-2461.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
L and Roles in Virulence and in Global Regulation of Gene Expression
Sébastien Rodrigue,2,
Giovanni Delogu,3
Roberta Provvedi,1
Liette Laflamme,2
Ryszard Brzezinski,4
Giovanni Fadda,3
Issar Smith,5
Luc Gaudreau,2
Giorgio Palù,1 and
Riccardo Manganelli1*
Department of Histology, Microbiology and Medical Biotechnologies, University of Padova, Padova, Italy,1 Centre de Recherche sur les Mécanismes du Fonctionnement Cellulaire, Université de Sherbrooke, Sherbrooke, Québec, Canada,2 Institute of Microbiology, Catholic University of the Sacred Hearth, Rome, Italy,3 Centre de Valorisation de la Diversité Microbienne, Département de Biologie, Université de Sherbrooke, Sherbrooke, Québec, Canada;,4 TB Center, The Public Health Research Institute, Newark, New Jersey5
Received 9 November 2005/ Returned for modification 12 December 2005/ Accepted 23 January 2006
| ABSTRACT |
|---|
|
|
|---|
| TEXT |
|---|
|
|
|---|
B-encoding gene (sigB) is induced in response to several stimuli (4, 14, 17, 18), suggesting a potential general role in stress responses (16, 24). Previous studies have shown that transcription of sigB can be initiated at the same nucleotide by RNAP holoenzymes that contain extracytoplasmic-function sigma factor
E or
H (17, 18, 21). It was also recently reported that the extracytoplasmic-function sigma factor
L may also have a role in the expression of sigB (11, 16).
Using an in vitro transcription assay, we have tested each M. tuberculosis sigma factor to determine whether additional sigma factors could elicit transcription of sigB. Reactions were performed as previously described (3) using purified Mycobacterium smegmatis RNAP, 150 fmol of sigB DNA template (encompassing base pairs 361 to +329 relative to the first translated nucleotide), and 3 pmol of recombinant sigma factors (13). As expected, primer extension products were detected for the
E- and
H-containing holoenzymes (Fig. 1A). Interestingly, the
L-dependent transcription signal also originated from the same nucleotide (Fig. 1A). Importantly, the
E-,
H-, and
L-dependent signals matched the sigB transcriptional start site identified in vivo (17, 21). In addition, an upstream
F-dependent promoter with striking homology to the proposed
F consensus was identified (Fig. 1A) (3, 9, 16). No signal was observed with the nine remaining M. tuberculosis sigma factors (data not shown). Primer extension assays were performed according to standard procedures using the following oligonucleotide: Mtb sigB-EXT (5'-ATCCAGATCGCTGTCAACCCGG-3'). A putative promoter closely resembling the
E-
H-
L-dependent sigB promoter was also found upstream of sigL. In vitro transcription was thus performed as in Fig. 1A using a sigL DNA template (base pairs 345 to +138 relative to the translation start site) and oligonucleotide Mtb sigL-EXT (5'-CTCTTGGACGACGTCTTC-3'). Interestingly,
L was the only sigma factor that allowed transcription from this promoter, suggesting that minor divergences in DNA sequences may account for promoter discrimination by
E,
H, and
L (Fig. 1B).
|
L anti-sigma factor and detected an interaction between these proteins in a bacterial two-hybrid assay (11). Since RslA is a predicted transmembrane protein, we have fused its cytoplasmic moiety (amino acids 1 to 114) to glutathione S-transferase (GST) and performed direct interaction assays with hexahistidine-tagged
E,
F,
H, and
L. Assays were performed as previously described (3) and analyzed by immunoblotting using anti-His antibody. Figure 2A shows a direct interaction between
L and GST-RslA. No interaction was detected between GST-RslA and
E,
F, and
H or between GST and any sigma factor (Fig. 2A and data not shown). In vitro transcription assays next demonstrated that RslA inhibits
L-dependent transcription of the sigB gene in a dose-dependent manner (Fig. 2B). In this latter experiment, increasing concentrations (1.5, 3.0, 6.0, and 12 pmol) of the N-terminally hexahistidine-tagged RslA cytoplasmic moiety were added to a fixed amount of
L-containing holoenzyme and sigB promoter template as described above for Fig. 1. Importantly, the
L-dependent signal was not affected by the addition of RshA or Rv1222, a
H (26) and a
E anti-sigma factor, respectively (data not shown). Taken together, these results demonstrate that RslA is a
L-specific anti-sigma factor.
|
Hahn and colleagues have shown that a sigL mutant of M. tuberculosis is attenuated in BALB/c mice in a high-dose intravenous infection model. We have performed a similar analysis using a low-dose aerosol infection model for two different mouse strains with different natural resistances to infection. C57BL/6 and DBA/2 mice were challenged, with
100 and 200 CFU/mouse of the TB1 or H37Rv strain (6). No major differences were observed in the abilities of the two strains to colonize lung and spleen tissues or in the size and extent of lesions as assessed by histopathology analysis at 28 and 60 days postinfection (Table 1 and data not shown). DBA/2 mice were also held for observation and determination of the time to death. A significant extension of the median survival time was observed for mice infected with the TB1 mutant compared to the parental strain, thus indicating that sigL is important for virulence (Fig. 3).
|
|
L-independent promoter located 130 bases upstream of sigL (11). However, by using a plasmid containing a fusion of the first 564 nucleotides upstream of sigL to lacZ, ß-galactosidase activity in the TB1 and wt strains (measured by the method of Miller [19]) tended to increase with culture density, especially in the transition from lag to exponential phase (Fig. 4).
|
L by mimicking naturally inducing conditions (release of
L by RslA), we have complemented the TB1 mutant strain by the introduction of sigL and its upstream region at the L5 integration site (12). The resulting "partially complemented" strain (TB3) thus contains sigL but not rslA, which should allow a constitutive activity of
L. A 25-fold induction of sigL was indeed measured by qRT-PCR in this strain with respect to the H37Rv strain (data not shown). The TB1 and TB3 strains were grown to mid-exponential phase, and the RNA expression profiles were compared using oligonucleotide microarrays as previously described (18). The resulting data were analyzed using the significance analysis of microarray method (28). A total of 27 genes from 12 putative transcription units were up-regulated in TB3 relative to TB1 (Table 2). No repressed genes were identified. Six induced genes were chosen, and their induction levels were confirmed by qRT-PCR (Table 2). The mRNA levels of the selected genes in H37Rv and TB1 mutant strains were also compared. All genes were expressed at similar levels in both strains, suggesting that inhibition of
L activity by RslA is virtually complete under these conditions (Table 2).
|
L from an acetamide-inducible promoter (11). Some genes (pks10, pks7, Rv1138c, mpt53, and Rv2877c) were identified by both approaches. However, the remaining four genes from the pks10 operon, three genes from the putative mmpL13 operon, four genes from the putative operon starting with Rv3166c, mce2F and its upstream gene, sigB, and others, were identified only in this work. Putative promoter boxes similar to those of in vitro-identified
L-dependent promoters (Fig. 1) and compatible with the proposed
L consensus sequence (11) were found upstream of eight of these genes (Table 2). Rapid amplification of cDNA end (5'-RACE) experiments, performed as previously described (17), confirmed that the transcriptional start sites of sigL, mmpL13A, and mpt53 were suitably located to allow
L to recognize these promoter elements (data not shown). Interestingly, although
E,
H, and
L all recognize the same promoter upstream of sigB, no other genes seem to be regulated by any combination of these sigma factors (17, 18). This suggests that although the consensus sequences recognized by these sigma factors are similar, few differences are sufficient for promoter discrimination.
Many of the genes regulated by
L could be involved in processes related to the cell envelope (Table 2). For example, the pks10 operon and ppsA gene products are likely to be involved in the biosynthesis of dimycocerosyl phthiocerol, an important component of the mycobacterial cell wall (1, 5, 8, 22, 23). Moreover, the mmpL13a and mmpL13b gene products belong to a family of proteins involved in lipid transport (5), sulfolipid biosynthesis (7), and peptidoglycolipid biogenesis (25). From this perspective, it is noteworthy that RslA is a predicted transmembrane protein that could possibly sense the condition of the cell envelope or an external signal. The absence of
L could thus result in a weakening the cell surface or in an inappropriate modulation of the host immune response by the bacterium, which could at least partially explain the attenuation of the sigL mutant reported in this paper and by others (11).
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
E.D. and S.R. contributed equally to this work. ![]()
| REFERENCES |
|---|
|
|
|---|
| 1. | Azad, A. K., T. D. Sirakova, N. D. Fernandes, and P. E. Kolattukudy. 1997. Gene knockout reveals a novel gene cluster for the synthesis of a class of cell wall lipids unique to pathogenic mycobacteria. J. Biol. Chem. 272:16741-16745. |
| 2. | Bardarov, S., S. Bardarov, Jr., M. S. Pavelka, Jr., V. Sambandamurthy, M. Larsen, J. Tufariello, J. Chan, G. Hatfull, and W. R. Jacobs, Jr. 2002. Specialized transduction: an efficient method for generating marked and unmarked targeted gene disruptions in Mycobacterium tuberculosis, M. bovis BCG and M. smegmatis. Microbiology 148:3007-3017. |
| 3. | Beaucher, J., S. Rodrigue, P. E. Jacques, I. Smith, R. Brzezinski, and L. Gaudreau. 2002. Novel Mycobacterium tuberculosis anti-sigma factor antagonists control SigF activity by distinct mechanisms. Mol. Microbiol. 45:1527-1540.[CrossRef][Medline] |
| 4. | Betts, J. C., P. T. Lukey, L. C. Robb, R. A. McAdam, and K. Duncan. 2002. Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling. Mol. Microbiol. 43:717-731.[CrossRef][Medline] |
| 5. | Camacho, L. R., P. Constant, C. Raynaud, M. A. Laneelle, J. A. Triccas, B. Gicquel, M. Daffe, and C. Guilhot. 2001. Analysis of the phthiocerol dimycocerosate locus of Mycobacterium tuberculosis. Evidence that this lipid is involved in the cell wall permeability barrier. J. Biol. Chem. 276:19845-19854. |
| 6. | Collins, F. M. 1985. Protection to mice afforded by BCG vaccines against an aerogenic challenge by three mycobacteria of decreasing virulence. Tubercle 66:267-276.[CrossRef][Medline] |
| 7. | Converse, S. E., and J. S. Cox. 2005. A protein secretion pathway critical for Mycobacterium tuberculosis virulence is conserved and functional in Mycobacterium smegmatis. J. Bacteriol. 187:1238-1245. |
| 8. | Dubey, V. S., T. D. Sirakova, M. H. Cynamon, and P. E. Kolattukudy. 2003. Biochemical function of msl5 (pks8 plus pks17) in Mycobacterium tuberculosis H37Rv: biosynthesis of monomethyl branched unsaturated fatty acids. J. Bacteriol. 185:4620-4625. |
| 9. | Geiman, D. E., D. Kaushal, C. Ko, S. Tyagi, Y. C. Manabe, B. G. Schroeder, R. D. Fleischmann, N. E. Morrison, P. J. Converse, P. Chen, and W. R. Bishai. 2004. Attenuation of late-stage disease in mice infected by the Mycobacterium tuberculosis mutant lacking the SigF alternate sigma factor and identification of SigF-dependent genes by microarray analysis. Infect. Immun. 72:1733-1745. |
| 10. | Gruber, T. M., and C. A. Gross. 2003. Multiple sigma subunits and the partitioning of bacterial transcription space. Annu. Rev. Microbiol. 57:441-466.[CrossRef][Medline] |
| 11. | Hahn, M. Y., S. Raman, M. Anaya, and R. N. Husson. 2005. The Mycobacterium tuberculosis extracytoplasmic-function sigma factor SigL regulates polyketide synthases and secreted or membrane proteins and is required for virulence. J. Bacteriol. 187:7062-7071. |
| 12. | Hatfull, G. F., and G. J. Sarkis. 1993. DNA sequence, structure and gene expression of mycobacteriophage L5: a phage system for mycobacterial genetics. Mol. Microbiol. 7:395-405.[Medline] |
| 13. | Jacques, J.-F., S. Rodrigue, R. Brzezinski, and L. Gaudreau. 2006. A recombinant Mycobacterium tuberculosis in vitro transcription system. FEMS Microbiol. Lett. 255:140-147.[CrossRef][Medline] |
| 14. | Manganelli, R., E. Dubnau, S. Tyagi, F. R. Kramer, and I. Smith. 1999. Differential expression of 10 sigma factor genes in Mycobacterium tuberculosis. Mol. Microbiol. 31:715-724.[CrossRef][Medline] |
| 15. | Manganelli, R., L. Fattorini, D. Tan, E. Iona, G. Orefici, G. Altavilla, P. Cusatelli, and I. Smith. 2004. The extra cytoplasmic function sigma factor SigE is essential for Mycobacterium tuberculosis virulence in mice. Infect. Immun. 72:3038-3041. |
| 16. | Manganelli, R., R. Provvedi, S. Rodrigue, J. Beaucher, L. Gaudreau, and I. Smith. 2004. Sigma factors and global gene regulation in Mycobacterium tuberculosis. J. Bacteriol. 186:895-902. |
| 17. | Manganelli, R., M. I. Voskuil, G. K. Schoolnik, E. Dubnau, M. Gomez, and I. Smith. 2002. Role of the extracytoplasmic-function sigma factor SigH in Mycobacterium tuberculosis global gene expression. Mol. Microbiol. 45:365-374.[CrossRef][Medline] |
| 18. | Manganelli, R., M. I. Voskuil, G. K. Schoolnik, and I. Smith. 2001. The Mycobacterium tuberculosis ECF sigma factor SigE: role in global gene expression and survival in macrophages. Mol. Microbiol. 41:423-437.[CrossRef][Medline] |
| 19. | Miller, J. H. 1992. A short course in bacterial genetics: a laboratory manual and handbook for Escherichia coli and related bacteria. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. |
| 20. | Raman, S., R. Hazra, C. C. Dascher, and R. N. Husson. 2004. Transcription regulation by the Mycobacterium tuberculosis alternative sigma factor SigD and its role in virulence. J. Bacteriol. 186:6605-6616. |
| 21. | Raman, S., T. Song, X. Puyang, S. Bardarov, W. R. Jacobs, Jr., and R. N. Husson. 2001. The alternative sigma factor SigH regulates major components of oxidative and heat stress responses in Mycobacterium tuberculosis. J. Bacteriol. 183:6119-6125. |
| 22. | Rousseau, C., T. D. Sirakova, V. S. Dubey, Y. Bordat, P. E. Kolattukudy, B. Gicquel, and M. Jackson. 2003. Virulence attenuation of two Mas-like polyketide synthase mutants of Mycobacterium tuberculosis. Microbiology 149:1837-1847. |
| 23. | Sirakova, T. D., V. S. Dubey, M. H. Cynamon, and P. E. Kolattukudy. 2003. Attenuation of Mycobacterium tuberculosis by disruption of a mas-like gene or a chalcone synthase-like gene, which causes deficiency in dimycocerosyl phthiocerol synthesis. J. Bacteriol. 185:2999-3008. |
| 24. | Smith, I. 2003. Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence. Clin. Microbiol. Rev. 16:463-496. |
| 25. | Sonden, B., D. Kocincova, C. Deshayes, D. Euphrasie, L. Rhayat, F. Laval, C. Frehel, M. Daffe, G. Etienne, and J. M. Reyrat. 2005. Gap, a mycobacterial specific integral membrane protein, is required for glycolipid transport to the cell surface. Mol. Microbiol. 58:426-440.[CrossRef][Medline] |
| 26. | Song, T., S. L. Dove, K. H. Lee, and R. N. Husson. 2003. RshA, an anti-sigma factor that regulates the activity of the mycobacterial stress response sigma factor SigH. Mol. Microbiol. 50:949-959.[CrossRef][Medline] |
| 27. | Sun, R., P. J. Converse, C. Ko, S. Tyagi, N. E. Morrison, and W. R. Bishai. 2004. Mycobacterium tuberculosis ECF sigma factor sigC is required for lethality in mice and for the conditional expression of a defined gene set. Mol. Microbiol. 52:25-38.[CrossRef][Medline] |
| 28. | Tusher, V. G., R. Tibshirani, and G. Chu. 2001. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. USA 98:5116-5121. |
| 29. | Wu, S., S. T. Howard, D. L. Lakey, A. Kipnis, B. Samten, H. Safi, V. Gruppo, B. Wizel, H. Shams, R. J. Basaraba, I. M. Orme, and P. F. Barnes. 2004. The principal sigma factor sigA mediates enhanced growth of Mycobacterium tuberculosis in vivo. Mol. Microbiol. 51:1551-1562.[CrossRef][Medline] |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|